ANTORIS MR 35mg MR tablet contains Trimetazidine Dihydrochloride 35 mg (Modified Release). It is an anti-anginal and anti-ischaemic medicine used as an add-on therapy for the symptomatic treatment of stable angina pectoris.
Uses:
Treatment of symptoms of stable angina pectoris (heart-related chest pain).
Helps improve the heart's energy metabolism during reduced oxygen supply.
Used as an additional therapy when standard anti-anginal medicines are not sufficient or not tolerated.
Helps improve exercise tolerance and reduce the frequency of angina symptoms.
Dose:
Take the dose exactly as prescribed by a physician.
Usually taken 35 mg twice daily with meals.
Swallow the modified-release tablet whole with water; do not crush or chew.
The dose and duration of treatment should be adjusted according to the patient's condition, kidney function, and physician's advice.